Improving compliance with appropriateness of testing for heparin-induced thrombocytopaenia: a quality improvement report

• Published in: BMJ open quality Vol. 11; no. 3; p. e001746
• Main Authors: Mericliler, Meric, Kazakova, Vera, Nicolas, Diala, Acharya, Utkarsh H, Jaber, Bertrand L
• Format: Journal Article
• Language: English
• Published: London British Medical Journal Publishing Group 01.07.2022; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Anticoagulants; education; healthcare quality improvement; Iatrogenesis; iatrogenic disease; Medical tests; Quality improvement; Quality Improvement Report; Quality of care; Side effects; Thrombocytopenia
• ISSN: 2399-6641; 2399-6641
• DOI: 10.1136/bmjoq-2021-001746

Heparin-induced thrombocytopaenia (HIT) is a serious complication of heparin therapy. Evidence-based guidelines recommend the use of the 4Ts scoring system to calculate pretest probability of HIT. However, this scoring system is often underused, and inappropriate testing can lead to increased morbidity, medical costs and length of hospital stay. We identified that inappropriate testing for HIT was common at our institution and implemented structured multicomponent educational interventions to evaluate the impact of education on the appropriateness of HIT testing. The educational interventions led to a significantly increased rate of appropriateness of HIT testing (69% vs 35%; p=0.001). In addition, the 4Ts score documentation rate significantly improved following the intervention (52% vs 17%; p=0.001). The rates of discontinuation of heparin products and initiation of alternative anticoagulation increased, although not statistically significantly. Educational interventions can improve compliance with evidence-based guidelines on appropriateness of testing for HIT.